Surgical Devices Developers Ltd 10434950 that of a importer and exporter false 1 November 2022 10434950 2022-11-01 2023-10-31 10434950 2022-10-31 10434950 2023-10-31 10434950 2021-11-01 2022-10-31 10434950 2021-10-31 10434950 2022-10-31 10434950 frs102-bus:FRS102 2022-11-01 2023-10-31 10434950 frs102-bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 10434950 frs102-bus:FullAccounts 2022-11-01 2023-10-31 10434950 frs102-bus:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 10434950 frs102-core:CurrentFinancialInstruments 2023-10-31 10434950 frs102-core:CurrentFinancialInstruments 2022-10-31 10434950 frs102-core:ShareCapital 2023-10-31 10434950 frs102-core:ShareCapital 2022-10-31 10434950 frs102-core:RetainedEarningsAccumulatedLosses 2023-10-31 10434950 frs102-core:RetainedEarningsAccumulatedLosses 2022-10-31 10434950 frs102-bus:Director1 2022-11-01 2023-10-31 10434950 frs102-bus:OrdinaryShareClass1 2023-10-31 10434950 frs102-bus:OrdinaryShareClass1 2022-10-31 10434950 frs102-bus:OrdinaryShareClass1 2022-11-01 2023-10-31 xbrli:pure iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares
Registered number
10434950
Surgical Devices Developers Ltd
Unaudited Accounts
for the year ended
31 October 2023
Surgical Devices Developers Ltd
Balance Sheet
as at 31 October 2023
Notes
2023
£
2022
£
Current assets
Debtors 497,336 2,497,214
Investments 0 235,143
Cash at bank and in hand 31,347 233,310
528,683 2,965,667
Prepayments and accrued income: 10,943 0
Creditors: amounts falling due within one year (1,478,119) (2,628,796)
Net current assets / (liabilities) (938,493) 336,871
Total assets less current liabilities (938,493) 336,871
Provisions for liabilities (0) (0)
Accruals and deferred income (34,021) (0)
Total net assets (liabilities) (972,514) 336,871
Capital and reserves
Called up share capital 3 10,000 10,000
Profit and loss account (982,514) 326,871
Shareholders' funds (972,514) 336,871

Surgical Devices Developers Ltd
Balance Sheet
as at 31 October 2023



These accounts have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The directors have not delivered a copy of the company's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006.

For the year ending 31 October 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Signed on behalf of the board of directors

...............................

Mr M Mercant Santa Cruz

Director


Approved by the board on 18 July 2024

Company Number: 10434950 (a Private Company Limited by Shares registered in England and Wales)

Registered Office:

Kemp House
160 City Road
London
EC1V 2NX
United Kingdom

Surgical Devices Developers Ltd
Notes to the Accounts
for the year ended 31 October 2023

1. Accounting policies

Basis of preparation of financial statements
These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, and the Companies Act 2006. The presentation currency is sterling.
Going concern basis
The accounts have been prepared on the assumption that the company is able to carry on business as a going concern for the foreseeable future.
Revenue recognition
Revenue is measured at the fair value of the consideration received or receivable. Revenue is reduced for estimated customer returns, rebates and other similar allowances. Revenue from the sale of goods is recognised when goods are delivered and legal title has passed.
Foreign currencies
Transactions in foreign currencies other than the functional currency of the company are recorded at the rate of exchange on the date the transaction occurred. Monetary assets and liabilities in foreign currencies are translated at the rates prevailing at the end of the reporting period. All differences are taken to the profit and loss account. Non-monetary items measured at historic cost in a foreign currency are recorded at that historic value.
2. Employees
2023 2022
Average number of employees during the period 0 0

3. Share capital
2023 2022
£ £
Allotted, called up and fully paid:
10,000 (2022: 10,000) Ordinary shares of £1.00 each 10,000 10,000
10,000 10,000